Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on UK Healthcare Gazette.
Press releases published on May 9, 2025
Protein Purification and Isolation Market Poised to Triple by 2035: Biotech Breakthroughs & Personalized Medicine | FMI
EIN Presswire
·
May 9, 2025
Protein Purification and Isolation Market Insights – Size, Share …
Global Automated Cannabis Testing Market Set for Robust Growth, Projected to Achieve 11-13% CAGR from 2022 to 2032 | FMI
EIN Presswire
·
May 9, 2025
Automated Cannabis Testing Market Analysis – Growth …
4 Best Fat Burners for Women Over the Counter and Online 2025 - Top Fat Burning Supplements and Pills for Female Weight Loss - Wolfson Brands
GlobeNewswire
·
May 9, 2025
Glasgow, May 09, 2025 (GLOBE NEWSWIRE) -- Losing weight can be tough, especially when stubborn fat just doesn’t seem to budge. But here’s the good news: 2025 brings a new wave of powerful, over-the-counter fat burners and online supplements designed …
Best Bodybuilding Supplements: Top Legal Steroids & Supplements For Bodybuilding & Muscle Growth
GlobeNewswire
·
May 9, 2025
Glasgow, May 09, 2025 (GLOBE NEWSWIRE) -- Introduction: Best Bodybuilding Supplements to Accelerate Muscle Growth—Including Legal Steroids In the competitive world of fitness and bodybuilding, every rep, every gram of protein, and every supplement you take …
OXB to Present at the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
GlobeNewswire
·
May 9, 2025
OXB to Present at the 28th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) Oxford, UK – 9 May 2025: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces its participation in the 28th Annual …
Tiziana Life Sciences Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer's Patient Treated with Intranasal Foralumab
GlobeNewswire
·
May 9, 2025
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …